Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: A meta-analysis of 33 case-control studies

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dai, Yue E ^a   Tang, Linjun ^b   Healy, Jasmine ^c   Sinnett, Daniel ^c,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Tongling People's Hospital of Anhui Province   (China)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; IKZF1 PROTEIN, HUMAN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AFRICAN; ARTICLE; CASE CONTROL STUDY; CHILDHOOD LEUKEMIA; CONFIDENCE INTERVAL; DATA EXTRACTION; DNA POLYMORPHISM; EMBASE; ETHNIC GROUP; ETHNICITY; EUROPEAN; GENE; GENETIC MODEL; HUMAN; IKZF1 GENE; MEDLINE; META ANALYSIS (TOPIC); PRE B LYMPHOCYTE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; STATISTICAL ANALYSIS; WEB OF SCIENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IKAROS TRANSCRIPTION FACTOR; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PUBLICATION BIAS;

EID: 84912521102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113748     Document Type: Article

References (40)

1. Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52: 682-703.
2. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, et al. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114: 937-951.
3. Eden T (2010) Aetiology of childhood leukaemia. Cancer Treat Rev 36: 286-297.
4. Greaves M (1999) Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 35: 173-185.
5. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, et al. (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41: 1006-1010.
6. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, et al. (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41: 1001-1005.
7. Lin CY, Li MJ, Chang JG, Liu SC, Weng T, et al. (2014) High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan. Blood Cells Mol Dis 52: 140-145.
8. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95: 1608-1611.
9. Vijayakrishnan J, Sherborne AL, Sawangpanich R, Hongeng S, Houlston RS, et al. (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51: 1870-1874.
10. Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, et al. (2013) Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer 60: 31-34.
11. Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Corda E, et al. (2013) Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)? Leukemia 27: 746-748.
12. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, te Kronnie G, et al. (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26: 902-909.
13. Emerenciano M, Barbosa TC, Lopes BA, Blunck CB, Faro A, et al. (2014) ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia. BMC Cancer 14: 127.
14. Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J (2004) Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 19: 419-428.
15. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and metaanalysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201-211.
16. Wu J, Liu J, Zhou Y, Ying J, Zou H, et al. (2012) Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis. Clin Cancer Res 18: 3972-3981.
17. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP (2008) Meta-analysis methods. Adv Genet 60: 311-334.
18. Zintzaras E, Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61: 634-645.
19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
20. Huy NT, Thao NT, Diep DT, Kikuchi M, Zamora J, et al. (2010) Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care 14: R240.
21. Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
22. Jackson D, Turner R, Rhodes K, Viechtbauer W (2014) Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models. BMC Med Res Methodol 14: 103.
23. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
24. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
25. Lautner-Csorba O, Gezsi A, Semsei AF, Antal P, Erdelyi DJ, et al. (2012) Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 5: 42.
26. Linabery AM, Blommer CN, Spector LG, Davies SM, Robison LL, et al. (2013) ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leuk Res 37: 936-942.
27. Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, et al. (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26: 2561-2564.
28. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, et al. (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115: 1765-1767.
29. Wang Y, Chen J, Li J, Deng J, Rui Y, et al. (2013) Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene 524: 203-207.
30. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, et al. (2013) Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 105: 733-742.
31. Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, et al. (2002) The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell 10: 1403-1415.
32. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, et al. (1994) The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156.
33. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, et al. (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453: 110-114.
34. Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, et al. (2011) IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci 102: 1874-1881.
35. Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, et al. (2009) IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 27: 5202-5207.
36. Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350: 1535-1548.
37. Kersey JH (1997) Fifty years of studies of the biology and therapy of childhood leukemia. Blood 90: 4243-4251.
38. Pui CH (2000) Acute lymphoblastic leukemia in children. Curr Opin Oncol 12: 3-12.
39. McNeil DE, Cote TR, Clegg L, Mauer A (2002) SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia. Med Pediatr Oncol 39: 554-557; discussion 552-553.
40. Greaves MF (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 2: 120-125.